Brief: Meridian Bioscience Says Obtained Merger Approval For All Relevant Antitrust And FDI Filings Except For Filing Related To CFIUS

VivoPower

11/10/2022 22:51

Oct 11 (Reuters) - Meridian Bioscience Inc  VIVO.O :
    * MERIDIAN BIOSCIENCE INC - AS OF OCTOBER 11, OBTAINED
MERGER
APPROVAL  FOR ALL RELEVANT ANTITRUST AND FDI FILINGS EXCEPT FOR
FILING RELATED TO CFIUS
    * MERIDIAN BIOSCIENCE INC - CFIUS APPLICATION WAS ACCEPTED
FOR
REVIEW, WITH OCTOBER 6, 2022 CONSTITUTING FIRST DAY OF INITIAL
REVIEW PERIOD
    * MERIDIAN BIOSCIENCE INC - MERIDIAN HAS NOT YET REACHED A
RESOLUTION WITH DOJ WITH RESPECT TO DOJ INVESTIGATION
    * MERIDIAN BIOSCIENCE INC - MERIDIAN CONTINUES TO ACTIVELY
WORK
WITH DOJ TO FIND A RESOLUTION TO DOJ INVESTIGATION
    * MERIDIAN BIOSCIENCE INC - AS OF OCTOBER 11, 2022, MERIDIAN
CONTINUES TO EXPECT TO COMPLETE MERGER IN FOURTH CALENDAR
QUARTER OF 2022

Further company coverage:  VIVO.O 
 ((Reuters.Briefs@thomsonreuters.com;))